New shot aims to stop debilitating skin itch
NCT ID NCT06366750
Summary
This study is testing an investigational drug called barzolvolimab to see if it can safely reduce severe itching and improve skin lesions in adults with prurigo nodularis. About 140 participants will receive either the drug or a placebo via injection every four weeks for 24 weeks. The main goal is to see if the drug provides significant itch relief by week 12.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PRURIGO NODULARIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Advanced Clinical Research Institute
Tampa, Florida, 33607, United States
-
Apex Clinical Research Center - Canton
Canton, Ohio, 44718, United States
-
Biobrilliance Medical Research Center
Hialeah, Florida, 33106, United States
-
Cahaba Dermatology Skin Health Center
Birmingham, Alabama, 35244, United States
-
Center for Clinical Studies
Webster, Texas, 77598, United States
-
Center for Dermatology Clinical Research, Inc
Fremont, California, 94538, United States
-
Centricity Research
Columbus, Georgia, 31904, United States
-
Centrum Medyczne Pratia Katowice
Katowice, Poland
-
Centrum Nowoczesnych Terapii "Dobry Lekarz"
Krakow, Małopolska, Poland
-
Clinical /research group Z.o.o.
Warsaw, Poland
-
Columbia Dermatology and Aesthetics
Columbia, South Carolina, 29212, United States
-
Complexo Hospitalario Universitario de Santiago de Compostela
A Coruña, Spain
-
DERMACEUM Centrum Badan
Wroclaw, Poland
-
DS Research of Kentucky, LLC
Louisville, Kentucky, 40241, United States
-
DS Research of Southern Indiana, LLC
Clarksville, Indiana, 47129, United States
-
Derm Effects
London, Ontario, Canada
-
Dermatology Institute & Skin Care Center
Santa Monica, California, 90404, United States
-
Dermatology Treatment and Research Center
Dallas, Texas, 75230, United States
-
Emory University
Atlanta, Georgia, 30322, United States
-
Empire Clinical Research
Pomona, California, 91767, United States
-
Encore Medical Research
Hollywood, Florida, 33024, United States
-
Encore Medical Research Boynton Beach
Boynton Beach, Florida, 33436, United States
-
Encore Medical Research of Weston
Weston, Florida, 33331, United States
-
Equity Medical
Bowling Green, Kentucky, 42104, United States
-
Equity Medical
New York, New York, 10023, United States
-
Fachklinik Bad Bentheim, Klinisches Studienzentrum
Bad Bentheim, Germany
-
Focus Clinical Research
West Hills, California, 91307, United States
-
FutureMeds - Madrid
Madrid, Spain
-
FutureMeds - Sevilla
Seville, Spain
-
FutureMeds Gdynia
Gdynia, Poland
-
Guelph Dermatology Research
Guelph, Ontario, Canada
-
Gyncentrum sp. z o.o.
Katowice, Poland
-
Gyncentrum sp. z o.o., NZOZ Gyncentrum - Oddział Warszawa
Warsaw, Poland
-
Hospital General Universitario Dr Balmis, ISABIAL
Alicante, Spain
-
Hospital de la Santa Creu i Sant Pau
Barcelona, Spain
-
Institut für Allergieforschung (IFA),Charité - Universitätsmedizin Berlin
Berlin, Germany
-
International Clinical Research - Tennessee LLC
Murfreesboro, Tennessee, 37130, United States
-
Investigate MD, LLC
Scottsdale, Arizona, 85255, United States
-
Katholisches Klinikum Bochum
Bochum, Germany
-
Kingsway Clinical Research
Etobicoke, Ontario, Canada
-
Klinika Ambroziak Dermatologia
Warsaw, Poland
-
LUXDERM Specjalistyczny Gabinet
Lublin, Poland
-
Life Arc Research Centers Corp
Miami, Florida, 33126, United States
-
Medisearch, LLC
Saint Joseph, Missouri, 64506, United States
-
MetroMed Clinical Trials
Chicago, Illinois, 60614, United States
-
North York Research Inc
Toronto, Ontario, Canada
-
Paddington Testing, PO
Philadelphia, Pennsylvania, 01913, United States
-
Pratia MCM Krakόw
Krakow, Poland
-
Profound Research LLC
Oceanside, California, 92056, United States
-
Revival Research Institute, LLC
Troy, Michigan, 48084, United States
-
Scottsdale Clinical Trials
Scottsdale, Arizona, 85260, United States
-
SimcoDerm Medical and Surgical Dermatology Center
Barrie, Ontario, Canada
-
Skin Specialists PC
Omaha, Nebraska, 68144, United States
-
Solmed Clinic
Zagreb, Croatia
-
Special Hospital Medico
Rijeka, Croatia
-
Stratica Dermatology
Edmonton, Alberta, Canada
-
Total Dermatology
Birmingham, Alabama, 35203, United States
-
Treasure Valley Medical Research
Boise, Idaho, 83706, United States
-
UC Health Physicians Office Dermatology
Cincinnati, Ohio, 45219, United States
-
University Hospital Center - Rijeka
Rijeka, Croatia
-
University Hospital Heidelberg
Heidelberg, Germany
-
University of California San Francisco
San Francisco, California, 94115, United States
-
University of California, San Francisco
San Francisco, California, 94115, United States
-
University of Miami
Miami, Florida, 33134, United States
-
University of New Mexico Department of Dermatology
Albuquerque, New Mexico, 87102, United States
-
Universitätsklinikum Augsburg
Augsburg, Germany
-
Universitätsklinikum Erlangen - Hautklinik
Erlangen, Germany
-
Universitätsklinikum Münster (UKM)
Münster, Germany
-
Universitätsklinikum RWTH Aachen- Dermatology
Frankfurt, 52074, Germany
-
Universitätsklinikum Tübingen - Hautklinik
Tübingen, Germany
-
Universtätsklinikum Frankfurt, Klinik für Dermatologie, Venerologie und
Frankfurt, Germany
-
Uniwersytecki Szpital Kliniczny im. Fryderyka Chopina w Rzeszowie
Rzeszów, Poland
Conditions
Explore the condition pages connected to this study.